REACH authorization is a regulatory process established by Regulation (EC) No. 1907/2006, known as the REACH Regulation (Registration, Evaluation, Authorisation, and Restriction of Chemicals), which applies to particularly hazardous chemical substances. The goal of the authorization is to ensure that substances of very high concern (SVHC) are progressively replaced with less hazardous alternatives, whenever possible.

Companies wishing to continue using or placing such substances on the market must apply for authorization, demonstrating that the substance's use is safe for human health and the environment, or that there are no technically and economically feasible alternatives. The process includes the preparation of a technical dossier and a risk assessment, which are submitted to the European Chemicals Agency (ECHA). Producers, importers, or users of substances listed in Annex XIV of the REACH Regulation are required to obtain this specific authorization from the European Union to demonstrate that the risks associated with such substances are adequately controlled, or that the socio-economic impact of not using them would be excessively high.

This authorization procedure automatically creates a cascading effect on all actors in the supply chain who use these substances. These actors will, in fact, be subject to strict controls by the authorities, who will monitor their correct adherence to the operating conditions and the relative risk management measures for any authorized use.

With this service, we are able to support you in all phases and aspects related to the use of substances under authorization. Our services include:

  • Assisting companies in applying for and renewing authorizations
  • Supporting companies in defining strategies for eliminating highly dangerous substances and conducting related investigations for their substitution
  • Identifying, evaluating, and implementing all risk management measures (sampling, exposure estimates, etc.) within company facilities as required by the authorization decisions

For this reason, we have defined a series of interventions that support companies in all phases and aspects related to the use of substances under authorization. This include:

  • Support in identifying uses and communication upstream in the chain and to ECHA (European Chemicals Agency)
  • Support in preparing documents to be sent to ECHA, such as the study on alternatives
  • Revision of safety data sheets and labeling according to the REACH Regulation for the substance subject to authorization
  • Conformity assessment with respect to exposure scenarios for the substances in question
  • Definition of an air testing strategy for substances based on what is defined in the authorization decision
  • Carrying out environmental and personal sampling for exposure assessment
  • Support in sending data to the supplier and ECHA if required
  • Support in revising, if necessary, preventive and protective measures (including PPE)
  • Updating chemical and/or carcinogenic/mutagenic/reprotoxic risk assessment documents
  • Support in managing the obligations foreseen by Chapter II

Request
information

I've read thePrivacy Policy.